Given that intracellular MIF has been reported to have a beneficial role in improving cell homeostasis and that secreted and extracellular MIF has various pro-tumourigenic and pro-inflammatory effects, it is conceivable that the clinicopathological role of MIF in breast cancer is complex and may vary with tumour stage and type. Here, MIF is linked to neoplasm.